Related Experiment Video
Updated: Aug 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Percutaneous coronary interventions in patients with ischemic heart disease and chronic renal failure]
1Samodzielna Pracownia Hemodynamiki Instytutu Kardiologii w Warszawie. witkowski@hbz.pl
Insights
Patients with chronic renal failure (CRF) undergoing percutaneous coronary interventions (PCI) for ischemic heart disease (IHD) face poor long-term survival. Coronary artery bypass graft (CABG) surgery may offer better long-term outcomes for select CRF patients.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Context:
- Chronic renal failure (CRF) affects 10% of patients with ischemic heart disease (IHD) undergoing percutaneous coronary interventions (PCI).
- CRF patients exhibit increased risks of major adverse cardiac events post-PCI.
- While coronary stents improve prognosis, long-term survival remains suboptimal in this population.
Purpose:
- To compare the efficacy and outcomes of percutaneous coronary interventions (PCI) versus coronary artery bypass graft (CABG) surgery in patients with chronic renal failure (CRF).
- To evaluate the long-term survival and adverse event rates associated with different revascularization strategies in CRF patients with ischemic heart disease (IHD).
Summary:
- Coronary artery bypass graft (CABG) surgery presents an alternative to PCI for CRF patients, offering potentially better long-term prognosis despite higher in-hospital mortality.
- CABG is likely the preferred treatment for CRF patients with multivessel coronary artery disease, left main stenosis, or diabetes.
- The impact of drug-eluting stents on long-term survival in CRF patients is currently undetermined.
Impact:
- This analysis informs treatment decisions for ischemic heart disease (IHD) in patients with chronic renal failure (CRF).
- Highlights the need for further research into optimal revascularization strategies, including the role of drug-eluting stents, for CRF patients.
- Aims to improve long-term survival and reduce adverse cardiac events in this high-risk patient group.
Abstract:
Patients with chronic renal failure (CRF) consist of about 10% of all patients with ischemic heart disease (IHD) undergoing percutaneous coronary interventions (PCI). These patients have a higher rate of in-hospital and long-term major adverse cardiac events. Coronary stents improved prognosis in CRF patients, however long-term survival is still poor. Coronary artery bypass graft (CABG) surgery is an alternative modality of treatment, with better long-term prognosis but at the cost of higher in-hospital mortality. CABG surgery probably should be preferred in patients with CRF and multivessel coronary artery disease, left main stenosis or diabetes. The influence of drug-eluting stents on survival in patients with CRF is unknown.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Chronic Kidney Disease III: Interprofessional Care
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
